Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0001415889-24-020662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-02 | 2024-07-31+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $1.74 | +13.0K | 14.3K | +1,004% | +$22.6K |
| DM | 2024-08-02 | 2024-07-31+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | M | A | 11,454 | $1.74 | 12,745 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-01 | M | A | 1,507 | $1.74 | 14,252 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-07-31 | M | D | 906 | $0.00 | 0 | D | $1.74 · — to 2030-09-03 | 906 Common Stock | (F1) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-07-31 | M | D | 10,548 | $0.00 | 1,507 | D | $1.74 · — to 2030-09-03 | 10,548 Common Stock | (F2) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-08-01 | M | D | 1,507 | $0.00 | 0 | D | $1.74 · — to 2030-09-03 | 1,507 Common Stock | (F2) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |